AR HB1709

Adds Arkansas Code 4-86-111 defining "pharmaceutical manufacturer discount" to include coupon cards, price concessions, rebates, administrative fees, inflation payments, procurement-related fees, care management fees, and other fees that reduce net patient costs or secure drug formulary placement.

Prohibits pharmaceutical manufacturers and their affiliates from providing discounts on insulin products, with a limited exception for coupon cards provided directly to end users and adjudicated in real time using National Council for Prescription Drug Programs claims transmission standards.

Authorizes the Arkansas Attorney General to investigate violations and bring suit against pharmaceutical manufacturers that violate the discount restrictions.

Exempts the Arkansas Medicaid Program from the insulin discount restrictions.

Effective date is January 1, 2022.